TELA Bio (TELA) Shares Outstanding (Diluted Average) (2019 - 2026)

TELA Bio's Shares Outstanding (Diluted Average) history runs 8 years deep, the most recent figure standing at $57.3 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) rose 26.49% year-over-year to $57.3 million; the TTM figure through Mar 2026 stood at $57.3 million (up 26.49% YoY), while the FY2025 annual figure was $46.9 million, up 64.58% from the prior year.
• Shares Outstanding (Diluted Average) was $57.3 million for Q1 2026 at TELA Bio, up from $46.9 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $57.3 million in Q1 2026 to a low of $14.5 million in Q1 2022.
• Historically, Shares Outstanding (Diluted Average) has averaged $29.1 million across 5 years, with a median of $24.6 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Diluted Average) increased 0.68% in 2024, then soared 84.27% in 2025.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $16.3 million in 2022, then surged by 40.58% to $22.9 million in 2023, then advanced by 24.74% to $28.5 million in 2024, then surged by 64.58% to $46.9 million in 2025, then advanced by 21.96% to $57.3 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $57.3 million (Q1 2026), $46.9 million (Q4 2025), and $45.4 million (Q3 2025), per Business Quant data.